Skip to content
★ Sign in to follow
WB

WaferGen Bio-systems, Inc. Stock: price and insider trades · United States

No insider purchase over the last 90 days. The latest, by Carlson Rolland, was filed 21 Oct 2015.

WaferGen Bio-systems, Inc.: what insiders have been doing

This page follows insider dealings at WaferGen Bio-systems, Inc. as filed with SEC (Form 4). Nothing new has been filed by managers of WaferGen Bio-systems, Inc. in twelve months, the latest record being from 1 March 2017.

Since 2008, the database holds 92 purchases and 6 sales by insiders of the company.

This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Insider Decl.
202
Thresholds
n/a
Buy Volume
€3M
92 ops. · all time
Sell Volume
€2M
6 ops. · all time

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Financial data

as of FY 2015

FY ended December 2015 · cache

Income statement
Revenue6.4M
Gross profit3.5M55% margin
Net income-13.7M-213.7% margin
Last declaration on 1 March 2017
Declarations202 total
  • ●
    Chief Financial OfficerExecutives
    29,407 USD27SEC
    4,001 shares@ US$7.35100.0% of flowCommon StockSEC:0001368993-17-000028:0
  • ●
    DirectorExecutives
    62,563 USD19SEC
    8,512 shares@ US$7.35100.0% of flowCommon StockSEC:0001368993-17-000021:0
  • ●
    DirectorExecutives
    61,505 USD19SEC
    8,368 shares@ US$7.35100.0% of flowCommon StockSEC:0001368993-17-000025:0
  • ●
    CEO and PresidentExecutives
    367,507 USD30SEC
    50,001 shares@ US$7.35100.0% of flowCommon StockSEC:0001368993-17-000027:0
  • ●
    DirectorExecutives
    63,335 USD19SEC
    8,617 shares@ US$7.35100.0% of flowCommon StockSEC:0001368993-17-000023:0
  • ●
    DirectorExecutives
    61,571 USD19SEC
    8,377 shares@ US$7.35100.0% of flowCommon StockSEC:0001368993-17-000022:0
  • ●
    DirectorExecutives
    61,527 USD19SEC
    8,371 shares@ US$7.35100.0% of flowCommon StockSEC:0001368993-17-000024:0
  • ◆
    DirectorExecutives
    0SEC
    3,049 shares0Common StockSEC:0001368993-17-000004:0
  • ◆
    DirectorExecutives
    0SEC
    3,049 shares0Common StockSEC:0001368993-17-000006:0
  • ◆
    DirectorExecutives
    0SEC
    3,049 shares0Common StockSEC:0001368993-17-000002:0
  • ◆
    DirectorExecutives
    0SEC
    3,049 shares0Common StockSEC:0001368993-17-000003:0
  • ◆
    DirectorExecutives
    0SEC
    3,049 shares0Common StockSEC:0001368993-17-000005:0
  • ◆
    DirectorExecutives
    0SEC
    20,833 sharesCommon StockSEC:0001368993-16-000065:0
  • ◆
    DirectorExecutives
    0SEC
    20,833 sharesCommon StockSEC:0001368993-16-000067:0
  • ◆
    DirectorExecutives
    0SEC
    20,833 sharesCommon StockSEC:0001368993-16-000066:0
  • ◆
    DirectorExecutives
    0SEC
    20,833 sharesCommon StockSEC:0001368993-16-000068:0
  • ◆
    DirectorExecutives
    0SEC
    20,833 sharesCommon StockSEC:0001368993-16-000069:0
  • ▲
    CEO and PresidentExecutives
    0SEC
    200,000 sharesCommon StockSEC:0001140361-15-038163:0
    Canonical exit: 19 Jan 2016 (T+90)
  • ▼
    Related company / holdingExecutives
    665,515 USD0SEC
    305,282 shares@ US$2.18Common StockSEC:0001535264-15-000084:0
  • ▼
    Related company / holdingExecutives
    396,000 USD0SEC
    200,000 shares@ US$1.98Common StockSEC:0001535264-15-000084:1
  • ▼
    Related company / holdingExecutives
    54,772 USD0SEC
    17,010 shares@ US$3.22Common StockSEC:0001535264-15-000083:0
  • ▼
    Related company / holdingExecutives
    1M USD0SEC
    475,363 shares@ US$2.27Common StockSEC:0001535264-15-000083:1
  • ◆
    CEO and PresidentExecutives
    0SEC
    50,000 shares0Common StockSEC:0001140361-15-019176:0
  • ◆
    Chief Financial OfficerExecutives
    0SEC
    20,000 shares0Common StockSEC:0001140361-15-018567:0
  • ◆
    Chief Operating OfficerExecutives
    0SEC
    40,000 shares0Common StockSEC:0001140361-15-018568:0

25 of 202 declarations

About WaferGen Bio-systems, Inc.

WaferGen Bio-systems, Inc. is a biotechnology company focused on developing solutions for genomic research. It specializes in innovative technologies for DNA and RNA analysis.